Abstract
L-asparaginase, an antineoplastic drug used in the treatment of acute lymphoblastic leukemia (ALL), has been previously shown to inhibit the hepatic synthesis of thyroxine-binding globulin (TBG). In two children treated by this drug for ALL, a dramatic decrease in serum sex hormone-binding globulin (SHBG) concentrations was also observed. Serum SHBG levels were still below normal 10 days after L-asparaginase withdrawal. To ascertain whether this reduction was due to the inhibition of SHBG synthesis, SHBG was measured by an immunoradiometric assay (IRMA) in the medium from human hepatoblastoma-de-rived cells, Hep G2 cells, grown in the absence or presence of graded amounts of the drug from 0.1 nM to 0.1 mM. The results showed a dose-dependent inhibition of SHBG synthesis, with a 50% reduction of SHBG in the medium, assayed by IRMA, using 250 nM L-asparaginase. Furthermore, a time-dependent inhibition was observed using a fixed concentration of the drug (50 nM) added for variable time intervals (1–4 days). These data suggest that the changes observed in vivo are likely due to the inhibitory effect exerted by the drug on SHBG synthesis. This action is not specific, but is part of a general effect at the hepatic level.
References
Haskell C.M., Canellos G.P., Leventhal B.G., Carbone P.P., Block J.B., Serpick A.A., Selawry O.S. L-asparaginase. Therapeutic and toxic effects in patients with neoplastic disease. N. Engl. J. Med. 281: 1028, 1969.
Whitecar J.P., Bodey G.P., Harris J.E., Freireich E.J. Current concepts of L-asparaginase. N. Engl. J. Med. 282: 732, 1970.
Capizzi R.L., Bertino J.R., Skeel R.T., Crearey W.A., Zanes R., Olayon C., Peterson R.C., Handschumacher R.E. L-asparaginase: clinical, biochemical, pharmacological and immunological studies. Ann. Intern. Med. 74: 893, 1971.
Bettigole R.E., Himelstein E.S., Oettgen H.F., Clifford G.O. Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131I-fibrinogen. Blood 35: 195, 1970.
Bezeaud A., Drouet L., Leverger G., Griffith J.H., Guillin M.-C. Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors. J. Pediatr. 108: 698, 1986.
Robbins J., Bartalena L. Plasma transport of thyroid hormones. In: Hennemann G. (Ed.), Metabolism of Thyroid Hormones. Marcel Dekker, New York, p. 3.
Garnick M.B., Larsen P.R. Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy. N. Engl. J. Med. 301: 252, 1979.
Heidemann P.H., Strubbe P., Beck W. Transient secondary hypothyroidism and thyroxinebinding globulin deficiency in leukemic children during polychemotherapy: An effect of L-asparaginase. Eur. J. Pediar. 136: 291, 1981.
Bartalena L., Tata J.R., Robbins J. Characterization of nascent and secreted thyroxine-binding globulin in cultured human hepatoma (Hep G2) cells. J. Biol. Chem. 259: 13605, 1984.
Murata Y., Same D.H., Horwitz A.L., Lecoq R., Aden D.P., Knowles B.B., Refetoff S. Characterization of thyroxine-binding globulin secreted by a human hepatoma cell line. J. Clin. Endocrinol. Metab. 60: 472, 1985.
Bartalena L., Martino E., Antonelli A., Pacchiarotti A., Robbins J., Pinchera A. Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (Hep G2) cells. Endocrinology 119: 1185, 1986.
Khan M.S., Knowles B.B., Aden D.P., Rosner W. Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line. J. Clin. Endocrinol. Metab. 53: 448, 1981.
Rosner W., Aden D.P., Khan M.S. Hormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell line. J. Clin. Endocrinol. Metab. 59: 806, 1984.
Lee I.R., Dawson S.A., Wetherall J.D., Hahnel R. Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens. J. Clin. Endocrinol. Metab. 64: 825, 1987.
Plymate S.R., Matej L.A., Jones R.E., Friedl K.E. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab. 67: 460, 1988.
Bartalena L., Robbins J. Effect of tunicamycin and monensin on secretion of thyroxine-binding globulin by cultured human hepatoma (Hep G2) cells. J. Biol. Chem. 259: 13610, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartalena, L., Martino, E., Pacchiarotti, A. et al. Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro . J Endocrinol Invest 12, 489–493 (1989). https://doi.org/10.1007/BF03350741
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350741